These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 30429288)

  • 1. Predicting Humoral Alloimmunity from Differences in Donor and Recipient HLA Surface Electrostatic Potential.
    Mallon DH; Kling C; Robb M; Ellinghaus E; Bradley JA; Taylor CJ; Kabelitz D; Kosmoliaptsis V
    J Immunol; 2018 Dec; 201(12):3780-3792. PubMed ID: 30429288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloantibody Responses After Renal Transplant Failure Can Be Better Predicted by Donor-Recipient HLA Amino Acid Sequence and Physicochemical Disparities Than Conventional HLA Matching.
    Kosmoliaptsis V; Mallon DH; Chen Y; Bolton EM; Bradley JA; Taylor CJ
    Am J Transplant; 2016 Jul; 16(7):2139-47. PubMed ID: 26755448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor/Recipient HLA Molecular Mismatch Scores Predict Primary Humoral and Cellular Alloimmunity in Kidney Transplantation.
    Meneghini M; Crespo E; Niemann M; Torija A; Lloberas N; Pernin V; Fontova P; Melilli E; Favà A; Montero N; Manonelles A; Cruzado JM; Palou E; Martorell J; Grinyó JM; Bestard O
    Front Immunol; 2020; 11():623276. PubMed ID: 33776988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DQ mismatches stimulate de novo donor specific antibodies in heart transplant recipients.
    Zhang X; Kransdorf E; Levine R; Patel JK; Kobashigawa JA
    Hum Immunol; 2020 Jul; 81(7):330-336. PubMed ID: 32307126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-DR/DQ molecular mismatch: A prognostic biomarker for primary alloimmunity.
    Wiebe C; Kosmoliaptsis V; Pochinco D; Gibson IW; Ho J; Birk PE; Goldberg A; Karpinski M; Shaw J; Rush DN; Nickerson PW
    Am J Transplant; 2019 Jun; 19(6):1708-1719. PubMed ID: 30414349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-human leukocyte antigen DQ antibodies in renal transplantation: Are we underestimating the most frequent donor specific alloantibodies?
    Carta P; Di Maria L; Caroti L; Buti E; Antognoli G; Minetti EE
    Transplant Rev (Orlando); 2015 Jul; 29(3):135-8. PubMed ID: 25976621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of tolerance to a maternal kidney transplant is selective for HLA class II: evidence from trans-vivo DTH and alloantibody analysis.
    Burlingham WJ; Jankowska-Gan E; VanBuskirk A; Orosz CG; Lee JH; Kusaka S
    Hum Immunol; 2000 Dec; 61(12):1395-402. PubMed ID: 11163098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: A new histocompatibility paradigm.
    Bryan CF; Chadha V; Warady BA
    Pediatr Transplant; 2016 Nov; 20(7):926-930. PubMed ID: 27448994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting HLA class II alloantigen immunogenicity from the number and physiochemical properties of amino acid polymorphisms.
    Kosmoliaptsis V; Sharples LD; Chaudhry AN; Halsall DJ; Bradley JA; Taylor CJ
    Transplantation; 2011 Jan; 91(2):183-90. PubMed ID: 21079553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degree of HLA class II eplet mismatch load improves prediction of antibody-mediated rejection in living donor kidney transplantation.
    Tafulo S; Malheiro J; Santos S; Dias L; Almeida M; Martins S; Pedroso S; Mendes C; Lobato L; Castro-Henriques A
    Hum Immunol; 2019 Dec; 80(12):966-975. PubMed ID: 31604581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preformed circulating HLA-specific memory B cells predict high risk of humoral rejection in kidney transplantation.
    Lúcia M; Luque S; Crespo E; Melilli E; Cruzado JM; Martorell J; Jarque M; Gil-Vernet S; Manonelles A; Grinyó JM; Bestard O
    Kidney Int; 2015 Oct; 88(4):874-87. PubMed ID: 26176829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor Specific Antibodies are not only directed against HLA-DR: Minding your Ps and Qs.
    Cross AR; Lion J; Loiseau P; Charron D; Taupin JL; Glotz D; Mooney N
    Hum Immunol; 2016 Nov; 77(11):1092-1100. PubMed ID: 27060781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitope analysis of HLA-DQ antigens: what does the antibody see?
    Tambur AR; Rosati J; Roitberg S; Glotz D; Friedewald JJ; Leventhal JR
    Transplantation; 2014 Jul; 98(2):157-66. PubMed ID: 25003284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation.
    DeVos JM; Gaber AO; Knight RJ; Land GA; Suki WN; Gaber LW; Patel SJ
    Kidney Int; 2012 Sep; 82(5):598-604. PubMed ID: 22622504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unexpected anti-HLA-DR and -DQ alloantibodies after nephrectomy of an HLA-DR and -DQ identical first renal transplant.
    Proust B; Kennel A; Ladrière M; Kessler M; Perrier P
    Transpl Immunol; 2009 Jul; 21(3):166-8. PubMed ID: 19341797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular HLA mismatching for prediction of primary humoral alloimmunity and graft function deterioration in paediatric kidney transplantation.
    Kim JJ; Fichtner A; Copley HC; Gragert L; Süsal C; Dello Strologo L; Oh J; Pape L; Weber LT; Weitz M; König J; Krupka K; Tönshoff B; Kosmoliaptsis V
    Front Immunol; 2023; 14():1092335. PubMed ID: 37033962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. More precise donor-recipient matching: the role of eplet matching.
    Wiebe C; Nickerson PW
    Curr Opin Nephrol Hypertens; 2020 Nov; 29(6):630-635. PubMed ID: 32889983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-A, B, C, DRB1, DQB1 matching heterogeneity in 'favourably matched' kidney recipients.
    Rees MT; Darke C
    Transpl Immunol; 2003; 12(1):73-8. PubMed ID: 14551034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical evaluation of a possible role of HLA epitope matching in kidney transplantation.
    Kumru Sahin G; Unterrainer C; Süsal C
    Transplant Rev (Orlando); 2020 Apr; 34(2):100533. PubMed ID: 32007300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted monitoring of donor-specific HLA antibodies following renal transplantation.
    Almeshari K; Pall A; Chaballout A; Elgamal H; Almana H; Alzayer F; Abaalkhail N; Altalhi M
    Clin Transpl; 2011; ():395-400. PubMed ID: 22755437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.